Key statistics
As of last trade, Atara Biotherapeutics Inc (AT20:BER) traded at 8.85, 86.22% above the 52 week low of 4.75 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 8.85 |
Low | 8.85 |
Bid | -- |
Offer | -- |
Previous close | 8.85 |
Average volume | -- |
---|---|
Shares outstanding | 5.66m |
Free float | 4.41m |
P/E (TTM) | -- |
Market cap | 43.72m USD |
EPS (TTM) | -39.90 USD |
Data delayed at least 15 minutes, as of Jun 18 2024 19:30 BST.
More ▼
Press releases
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Atara Biotherapeutics Announces $36 Million Registered Direct Offering
- Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
- Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
More ▼